Cargando…
Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability
BACKGROUND: A rapid and comprehensive metabolic stability screen at the top of a drug discovery flow chart serves as an effective gate in eliminating low value compounds. This imparts a significant level of efficiency and saves valuable resources. While microsomes are amenable to high throughput aut...
Autores principales: | Richardson, Samantha J., Bai, April, Kulkarni, Ashutosh A., Moghaddam, Mehran F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405623/ https://www.ncbi.nlm.nih.gov/pubmed/26902079 http://dx.doi.org/10.2174/1872312810666160223121836 |
Ejemplares similares
-
Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR‐Cas9 System
por: Han, Xin, et al.
Publicado: (2016) -
An Efficient Workflow for Screening and Stabilizing CRISPR/Cas9-Mediated Mutant Lines in Bombyx mori
por: Brady, Daniel, et al.
Publicado: (2020) -
Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR–Cas9 library
por: Wu, Yuanzhong, et al.
Publicado: (2016) -
Hierarchical virtual screening approaches in small molecule drug discovery
por: Kumar, Ashutosh, et al.
Publicado: (2015) -
Stability Analysis of an Extended SEIR COVID-19 Fractional Model with Vaccination Efficiency
por: Wali, Mubashara, et al.
Publicado: (2022)